Consistent with its functionally important role, SETD2 deletion is embryonically lethal and mutations in SETD2 have been reported in many cancers, including clear cell renal cell carcinoma (12, 13, 14, 15, 16, 17, 18). This evidence concerns the gene SETD2 and cancer.